Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:SM 18:1;O2/24:1(15Z))

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST002309 AN003771 Targeting malaria parasites with novel derivatives of azithromycin Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002150 AN003520 Sphingomyelin depletion inhibits CXCR4 dynamics and CXCL12-mediated directed cell migration in human T cells HEK cells Human Universidad CEU San Pablo LC-MS
ST002066 AN003365 Glutaminase inhibition impairs CD8 T cell activation in STK11/Lkb1 deficient lung cancer Lung Mouse Cancer Walter and Eliza Hall Institute of Medical Research LC-MS
ST001795 AN002915 Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) Mesenteric lymph Mouse Obesity Monash Institute of Pharmaceutical Sciences LC-MS
ST001788 AN002899 β-Adrenergic regulation of metabolism in macrophages (part-IV) Macrophages Human Monash University LC-MS
ST001549 AN002580 β-Adrenergic regulation of metabolism in macrophages (part-III) Macrophages Human Monash University LC-MS
ST001548 AN002578 β-Adrenergic regulation of metabolism in macrophages (part-II) Macrophages Human Monash University LC-MS
ST001547 AN002576 β-Adrenergic regulation of metabolism in macrophages Macrophages Human Monash University LC-MS
ST001315 AN002189 Retargeting azithromycin-like compounds as antimalarials with dual modality Blood Plasmodium falciparum Malaria Monash University LC-MS
ST001274 AN002115 Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) Cultured cells Trypanosoma brucei Sleeping sickness Monash University LC-MS
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001202 AN002000 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001202 AN002000 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST000620 AN000952 Sphingolipid Analysis of hyper and normotensive DBA2J mice aqueous humor and trabecular meshwork Eye tissue Mouse Eye disease University of Miami MS(Dir. Inf.)
ST000613 AN000938 Human TM Sphingolipid Analysis (part II) Eye tissue Human Eye disease University of Miami MS(Dir. Inf.)
ST000612 AN000937 Sphingolipid Analysis of Human Aqueous Humor in Glaucomatous and Control eyes Eye tissue Human Eye disease University of Miami MS(Dir. Inf.)
ST000539 AN000818 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash University LC-MS
ST000445 AN000696 Follicular fluid lipidomics reveals lipid alterations by LH addition during IVF cycles Follicular fluid Human Universidade Federal de Sao Paulo LC-MS
ST000414 AN000655 Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action Cells Plasmodium falciparum Malaria Monash Institute of Pharmaceutical Sciences LC-MS
ST000403 AN000642 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences LC-MS
ST000310 AN000490 TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) Blood Mouse Lupus University of Florida LC-MS
ST000310 AN000492 TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) Blood Mouse Lupus University of Florida LC-MS
  logo